BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33684566)

  • 1. GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling.
    Frohlich J; Mazza T; Sobolewski C; Foti M; Vinciguerra M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jun; 1866(6):158920. PubMed ID: 33684566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF11 restricts aberrant lipogenesis and changes in mitochondrial structure and function in human hepatocellular carcinoma cells.
    Hernandez S; Simoni-Nieves A; Gerardo-Ramírez M; Torres S; Fucho R; Gonzalez J; Castellanos-Tapia L; Hernández-Pando R; Tejero-Barrera E; Bucio L; Souza V; Miranda-Labra R; Fernández-Checa JC; Marquardt JU; Gomez-Quiroz LE; García-Ruiz C; Gutiérrez-Ruiz MC
    J Cell Physiol; 2021 May; 236(5):4076-4090. PubMed ID: 33174245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDF11 induces mild hepatic fibrosis independent of metabolic health.
    Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M
    Aging (Albany NY); 2020 Oct; 12(20):20024-20046. PubMed ID: 33126224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF11 inhibits adipogenesis and improves mature adipocytes metabolic function via WNT/β-catenin and ALK5/SMAD2/3 pathways.
    Frohlich J; Kovacovicova K; Raffaele M; Virglova T; Cizkova E; Kucera J; Bienertova-Vasku J; Wabitsch M; Peyrou M; Bonomini F; Rezzani R; Chaldakov GN; Tonchev AB; Di Rosa M; Blavet N; Hejret V; Vinciguerra M
    Cell Prolif; 2022 Oct; 55(10):e13310. PubMed ID: 35920128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice.
    Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C
    J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF11 impairs liver regeneration in mice after partial hepatectomy.
    Wang W; Yang X; Yang J; Liu S; Lv Y; Zhang C; Dong W; Liu A
    Clin Sci (Lond); 2019 Oct; 133(20):2069-2084. PubMed ID: 31654062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF11: An emerging therapeutic target for liver diseases and fibrosis.
    Habibi P; Falamarzi K; Ebrahimi ND; Zarei M; Malekpour M; Azarpira N
    J Cell Mol Med; 2024 Apr; 28(7):e18140. PubMed ID: 38494851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Binding Activity of TGF-β Family Proteins to Select TGF-β Receptors.
    Khalil AM; Dotimas H; Kahn J; Lamerdin JE; Hayes DB; Gupta P; Franti M
    J Pharmacol Exp Ther; 2016 Sep; 358(3):423-30. PubMed ID: 27340210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deranged hepatocyte intracellular Ca
    Ali ES; Rychkov GY; Barritt GJ
    Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration.
    Rochette L; Zeller M; Cottin Y; Vergely C
    Pharmacol Ther; 2015 Dec; 156():26-33. PubMed ID: 26523637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.
    Herrera B; Dooley S; Breitkopf-Heinlein K
    Int J Mol Sci; 2014 Mar; 15(4):5199-220. PubMed ID: 24670474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.
    Chen J; Chen J; Huang J; Li Z; Gong Y; Zou B; Liu X; Ding L; Li P; Zhu Z; Zhang B; Guo H; Cai C; Li J
    Aging (Albany NY); 2019 Dec; 11(23):10839-10860. PubMed ID: 31796646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells.
    Zhang YH; Cheng F; Du XT; Gao JL; Xiao XL; Li N; Li SL; Dong de L
    Oncotarget; 2016 Mar; 7(11):12063-74. PubMed ID: 26919250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDF11 Inhibits Bone Formation by Activating Smad2/3 in Bone Marrow Mesenchymal Stem Cells.
    Lu Q; Tu ML; Li CJ; Zhang L; Jiang TJ; Liu T; Luo XH
    Calcif Tissue Int; 2016 Nov; 99(5):500-509. PubMed ID: 27395058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion.
    Gerardo-Ramírez M; Lazzarini-Lechuga R; Hernández-Rizo S; Jiménez-Salazar JE; Simoni-Nieves A; García-Ruiz C; Fernández-Checa JC; Marquardt JU; Coulouarn C; Gutiérrez-Ruiz MC; Pérez-Aguilar B; Gomez-Quiroz LE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1540-1554. PubMed ID: 30890427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF11 Attenuates Development of Type 2 Diabetes via Improvement of Islet β-Cell Function and Survival.
    Li H; Li Y; Xiang L; Zhang J; Zhu B; Xiang L; Dong J; Liu M; Xiang G
    Diabetes; 2017 Jul; 66(7):1914-1927. PubMed ID: 28450417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism.
    M Onorato A; Fiore E; Bayo J; Casali C; Fernandez-Tomé M; Rodríguez M; Domínguez L; Argemi J; Hidalgo F; Favre C; García M; Atorrasagasti C; Mazzolini GD
    Liver Int; 2021 Jul; 41(7):1677-1693. PubMed ID: 33641248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.